Patents by Inventor Derrick C. WAN

Derrick C. WAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220409559
    Abstract: Methods of reducing skin fibrosis by prophylactically treating skin prior to radiation therapy are described herein. The methods include applying an effective amount of DFO to skin that may be subjected to radiation, e.g., during treatment for cancer at a treatment site. The DFO may be administered transdermally.
    Type: Application
    Filed: October 20, 2020
    Publication date: December 29, 2022
    Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Derrick C. WAN, Michael T. LONGAKER, Geoffrey C. GURTNER
  • Publication number: 20220241224
    Abstract: Methods of increasing perfusion and vascularity in irradiated tissue and of increasing retention of fat cells in a fat graft in irradiated tissue by applying an effective amount of DFO to the irradiated tissue at a treatment site. The DFO may be administered transdermally.
    Type: Application
    Filed: April 14, 2022
    Publication date: August 4, 2022
    Inventors: Derrick C. Wan, Geoffrey C. Gurtner, Michael T. Longaker
  • Patent number: 11331288
    Abstract: Methods of increasing perfusion and vascularity in irradiated tissue and of increasing retention of fat cells in a fat graft in irradiated tissue by applying an effective amount of DFO to the irradiated tissue at a treatment site. The DFO may be administered transdermally by applying a transdermal delivery device to a tissue surface at the treatment site in multiple discrete doses. The transdermal delivery system comprises DFO encapsulated in reverse micelles.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: May 17, 2022
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Derrick C. Wan, Geoffrey C. Gurtner, Michael T. Longaker
  • Patent number: 11180536
    Abstract: Antibodies specific for royalactin (RA) can be used in methods for purifying royalactin, including native royalactin. These methods produce can produce compositions enriched for native royalactin. The purified royalactin can be used to produce cosmetic products that include native royalactin. An isolated nucleic acid encodes a monoclonal antibody that binds specifically to royalactin.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: November 23, 2021
    Assignee: WYL SCIENCES INC.
    Inventors: George P. Yang, Kevin C. Wang, Derrick C. Wan
  • Publication number: 20200377560
    Abstract: Antibodies specific for royalactin (RA) can be used in methods for purifying royalactin, including native royalactin. These methods produce can produce compositions enriched for native royalactin. The purified royalactin can be used to produce cosmetic products that include native royalactin. An isolated nucleic acid encodes a monoclonal antibody that binds specifically to royalactin.
    Type: Application
    Filed: April 11, 2018
    Publication date: December 3, 2020
    Inventors: George P. Yang, Kevin C. Wang, Derrick C. Wan
  • Publication number: 20200253899
    Abstract: Methods of increasing perfusion and vascularity in irradiated tissue and of increasing retention of fat cells in a fat graft in irradiated tissue by applying an effective amount of DFO to the irradiated tissue at a treatment site. The DFO may be administered transdermally by applying a transdermal delivery device to a tissue surface at the treatment site in multiple discrete doses. The transdermal delivery system comprises DFO encapsulated in reverse micelles.
    Type: Application
    Filed: September 12, 2018
    Publication date: August 13, 2020
    Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Derrick C. WAN, Geoffrey C. GURTNER, Michael T. LONGAKER